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ABSTRACT 
Background and Objectives: The correlation between brain natruretic peptide (BNP) level and cardiac autonomic 
function has been studied in type 2 diabetic patients. However, there is limited data from patients with normal 
systolic function. We evaluated the association between heart rate recovery (HRR) representing autonomic dys-
function and three plasma BNP levels: pre-exercise, post-exercise, and change during exercise in patients with nor-
mal systolic function. Subjects and Methods: Subjects included 105 patients with chest pain and normal systolic 
function. HRR was defined as the difference between the peak heart rate and the rate measured two minutes 
after completion of a treadmill exercise test. We measured plasma BNP levels before exercise, 5 minutes after com-
pletion of exercise, and during exercise (absolute value of difference between pre- and post-exercise BNP levels). 
Results: Patients with abnormal HRR values (≤24 beats for the first 2 minutes of HRR) had lower high-den-
sity lipoprotein, lower peak heart rates, and higher pre- and post-exercise BNP levels than patients with normal 
HRR values. The patients with coronary artery disease (CAD) had abnormal HRR. However, no significant dif-
ferences were found between the two groups in terms of history of hypertension (HTN), diabetes, and peak systo-
lic blood pressure (SBP) and diastolic blood pressure (DBP). HRR was significantly associated with pre-exercise BNP 
(r=-0.36, p=0.004) and post-exercise BNP (r=-0.27, p=0.006), but not BNP changes. Further, pre-exercise BNP 
levels showed a greater association with HRR than post-exercise BNP levels. Conclusion: HRR is independently as-
sociated with pre-exercise and post-exercise BNP levels, even in patients with normal systolic function. (Korean 
Circ J 2010;40:172-178) 
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Introduction 
 
Heart rate recovery (HRR) is defined as the decline 
in heart rate immediately following exercise. The rapid 
deceleration of the heart rate immediately following ex-
ercise is dependent on a complex interplay between va-
rious intrinsic, neural, and humoral factors.
1-3) The de-
crease in heart rate immediately after exercise is a func-
tion of the reactivation of the parasympathetic nervous 
system.
2) There are cross-sectional associations of HRR 
with glucose, insulin, high-density lipoprotein-chole-
sterol (HDL-C), triglyceride (TG), blood pressure (BP), 
low-density lipoprotein-cholesterol (LDL-C).
4-8) Decreased 
HRR is a predictor of a poor cardiovascular prognosis, in-
dependent of and in addition to other risk factors.
9-11) 
Brain natruretic peptide (BNP) is a hormone that is 
released from the ventricles in response to an increase 
in left ventricular pressure and volume. Plasma BNP 
levels play a crucial role in the diagnosis and prognosis 
of heart failure (HF) patients.
12)13) Increased BNP levels 
have been observed in patients with hypertension (HTN), 
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atrial fibrillation, valvular heart disease, ST-segment ele-
vation myocardial infarction and myocardial ischemia 
without extensive necrosis.
14)15)  
Higher BNP levels are consistently observed in pa-
tients with HF and coronary artery disease (CAD) with 
blunted HRR.
15)16) Also, the correlation between BNP 
and cardiac autonomic function has been studied in 
type 2 diabetic patients.
17) However, there is limited data 
on the relationship between HRR and BNP levels in 
patients without HF. Also, there have been few studies 
of BNP levels before, after, and during exercise. The 
purpose of this study was to examine the association 
between HRR and plasma BNP levels before, after, and 
during exercise in patients with a normal systolic func-
tion and to determine important associated factors. 
 
Subjects and Methods 
 
Subjects  
This study was conducted at the Kangbuk Samsung 
Hospital and included 105 patients who had complain-
ed of chest pain but had no symptoms at admission, 
and had a probable diagnosis of coronary heart disease. 
Coronary angiography (CAG) and an exercise test were 
conducted on all patients. Of these patients, 40 were 
in the CAD group. We excluded patients with an echo-
cardiographic ejection fraction (EF) of ≤50%, respi-
ratory difficulty, pulmonary abnormalities, myocardial 
infarction or valvular disease, a history of cardiac sur-
gery or percutaneous transluminal coronary angioplasty 
(PTCA) or kidney disease. Patients were hospitalized and 
treated with aspirin and clopidogrel according to the 
attending physician’s judgment with regard to CAD. 
Other prescriptions, such as angiotensin converting en-
zyme inhibitor and beta-blockers, were continued and 
arranged to avoid duplicating existing HTN or diabetes 
drugs. No additional medications were taken. Informed 
consent was obtained from each patient in accordance 
with the Helsinki Declaration.   
 
Stress testing   
A stress test was conducted on patients after over-
night fasting. All patients underwent symptom-limited 
treadmill exercise testing according to the Bruce protocol 
and patients were continuously monitored by 12-lead 
electrocardiography. BP and heart rate were measured 
at rest, at 3-minute intervals during exercise, during peak 
effort and at 1-minute intervals during recovery. Test-
ing was interrupted for the following reasons: exhaus-
tion, a sustained drop in systolic blood pressure (SBP), 
clinical manifestations of intense typical chest pain, a ST 
segment depression of ≥2 mm, a ST segment elevation 
of  ≥2 mm in a lead without the presence of the Q wave 
or the development of arrhythmias. Patients with a ho-
rizontal or down-sloping ST segment depression of ≥1 
mm for at least 60 milliseconds to 80 milliseconds after 
the end of the QRS complex in two adjacent leads were 
considered positive for CAD.
18)  
 
Heart rate recovery 
After achieving the peak workload, all patients spent 
at least 2 minutes in a cool-down period during tread-
mill testing at a speed of 2.4 km per hour and a grade 
of 2.5 percent. This period was considered the recovery 
period. The value for the recovery of heart rate was de-
fined as the difference in the heart rate from the peak 
rate during exercise to the rate at 2 minutes after cessa-
tion of exercise. A cutoff HRR value of 24 beats per 2 
minutes was considered abnormal, reflecting a desired 
HRR value of 12 beats per minute. However, one minute 
is not sufficient for patient arrangement, inflation and 
deflation of the cuff to measure BP and HRR after the 
treadmill test. Also, a 2 minutes HRR may decrease more 
than a 1 minute HRR.
20) 
 
Coronary angiography and extent of severity   
Two cardiologists reviewed the angiograms indepen-
dently of each other in a blinded manner. Stenosis ex-
ceeding 50% of the major epicardial coronary artery 
diameter was considered significant.   
 
Brain natruretic peptide measurements   
All subjects were instructed to fast overnight before 
BNP level measurements. Plasma BNP levels were meas-
ured before exercise and after 5 minutes at sitting rest 
after completion of exercise. The BNP change is the ab-
solute value of the difference between pre- and post-ex-
ercise BNP levels. A polyethylene tube containing ethy-
lene diamine tetra-acetic acid was filled with 5 mL of 
blood. The plasma BNP concentrations were determined 
using the Triage BNP test kit (Biosite, San Diego, CA, 
USA), a fluorescent immunoassay method with a de-
tection limit of 5 pg/mL.   
 
Echocardiography  
M-mode echocardiography was performed under 2-
dimensional echocardiography guidance using an Agi-
lent Sonos 5500 (Hewlett Packard, Palo Alto, CA, USA) 
equipped with a 2.5-MHz transducer. Two-dimensional 
images taken from longitudinal or transverse parasternal 
views were used to ensure that all measurements were 
obtained at the same level. The following measurements 
were performed according to the recommendations of 
the American Society of Echocardiography: intraven-
tricular septal thickness at end-diastole (IVSTd), left 
ventricular internal dimension at end-diastole (LVIDd) 
and posterior wall thickness at end-diastole (PWTd). 
The left ventricular ejection fraction (LVEF) was meas-
ured according to the modified Simpson’s rule. The mi-
tral flow velocities (E: early filling velocity, A: late filling  
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velocity) were measured using a pulsed-wave Doppler, 
with the sample volume placed between leaflet tips. The 
Devereux and Reichek formula was used to calculate 
the left ventricular mass index (LVMI): LVMI={1.04×
[(LVIDd+3PWTd+LVIDd)
3-LVIDd
3]-13.6}/body sur-
face area. 
 
Statistical analysis   
Statistical analysis was conducted using Statistical Pa-
ckage for the Social Sciences (SPSS) version 12.0 software 
(SPSS corporation, Chicago, IL, USA) with advice from 
the statistics department in our hospital. Continuous 
variables are presented as mean values with standard 
deviation. The comparisons between the two groups of 
patients with abnormal HRR after exercise were perform-
ed using a t-test. A p≤0.05 (less than or equal to 0.05) 
was considered statistically significant. Multivariate re-
gression analysis was used to identify possible indepen-
dent variables associated with impaired HRR after ex-
ercise in patients with normal systolic function.   
 
Results  
 
Clinical characteristics   
The study group consisted of 105 subjects (64 men 
and 41 women). The base-line characteristics of the 
patients according to their HRR are shown in Table 1 
and 2. The 105 enrolled patients met all of the inclu-
sion criteria. A cutoff value of ≤24 beats for the first 2 
minutes of the HRR was found to maximize the log-
rank test statistic. An abnormal value for the HRR was 
found in 44 patients (42%). There was no significant 
difference in age, HTN, diabetes mellitus (DM) preval-
ence, body weight, total cholesterol, LDL-C, TG level, 
or BNP change between the normal HRR group and 
the abnormal HRR group (p>0.05). The abnormal HRR 
group had significantly higher pre- and post-exercise 
BNP levels than the normal HRR group (p=0.017). 
Seven patients (4 in normal HRR groups, and 3 in ab-
normal HRR groups) were taking beta-blockers but there 
was no significant difference in the two groups. In addi-
tion, the abnormal HRR group had a significant higher 
prevalence of CAD (p=0.011), which is probably due to 
the fact that women, but not men, had a significantly 
higher CAD prevalence in the abnormal HRR group 
(p=0.01 and p=0.24, respectively).  
 
Exercise electrocardiography test and echocardio-
graphic findings 
There was not a significant difference between the 
normal HRR group and the abnormal HRR group in 
the peak SBP and diastolic blood pressure (DBP), LVEF, 
LVIDd, LVIDs, IVSd, and cardiac index. There was a 
significant difference in peak heart rate (HR) and E/A 
ratio as shown in Table 1, 2. 
 
Correlation between brain natruretic peptide and 
heart rate recovery   
Correlation analysis showed that the HRR had a sig-
nificant negative association with pre-exercise BNP levels 
(p<0.01) (Table 3, Model 1). After correcting for the 
peak heart rate, CAD, age, HTN, and DM sequentially, 
the pre-exercise BNP level was significantly correlated 
with HRR (Table 3, Model 2). When the peak heart 
rate, CAD, age, HTN, and DM were corrected together, 
there was a significant negative correlation between the 
pre-exercise BNP level and HRR (p<0.05) (Table 3, Mo-
del 3).  
Table 4 and 5 show correlation analysis for post-ex-
ercise BNP and BNP change, respectively. HRR had a 
Table 1. Baseline characteristics according to HRR after exercise
  ≤24 bpm (n=44)  >24 bpm (n=61)     p 
 
Total  Men  Women  Total  Men  Women  Total  Men Women
Total (n=105) 44  26  18  61  38  23  0.45     
Age (year)  59.6±13.3 53.9±13.1 67.8±8.7 56.6±8.6 54.6±8.2 60.0±8.3 0.19  0.84 0.01
HTN 18/44  09/26  09/18 23/61 11/38  13/23  0.87  0.63 0.68
DM 10/44  05/26  05/18  08/61  05/38  03/23 0.20  0.73 0.27
Body weight (kg)  67.5±11.8 72.7±11.6 59.8±7.2 67.7±9.7 70.6±8.8 63.0±9.4 0.90  0.40 0.24
TC (mg/dL)  196.8±49.6 186.5±48.2 211.1±49.4 192.6±32.3 190.9±32.1 195.1±33.2 0.63 0.69 0.23
LDL-C (mg/dL)  115.6±36.3 107.3±32.7 127.3±38.6 110.6±32.5 106.9±27.0 116.8±39.8 0.47 0.96 0.40
HDL-C (mg/dL)  44.4±9.0 43.1±6.6 46.3±11.6 48.9±11.2 49.8±11.3 47.4±11.2 0.03 0.01 0.75
TG (mg/dL)  178.4±96.9 190.6±111.3 161.5±72.0 169.7±94.6 160.7±71.5 184.9±124.9 0.65  0.20 0.49
Pre-BNP (pg/mL)  51.0±64.9 27.8±37.9 84.6±80.7 18.2±24.8 16.0±27.9 21.9±18.5 0.02 0.26 0.01
Post-BNP (pg/mL)  080.8±118.6 39.8±49.1 140.0±160.5 27.5±30.5 24.9±31.4 32.1±29.0 0.02 0.02 0.92
BNP change (pg/mL)  29.8±70.1 12.1±18.0 55.4±103.8 9.35±18.9 8.8±10.7 10.3±18.2 0.83 0.59 0.32
Peak HR  125.7±23.2 132.1±19.8 116.5±25.2 140.9±18.6 143.9±18.6 135.8±18.0 0.00 0.02 0.01
CAD/Total 23/44  12/26  11/18  17/61  12/38  5/23  0.01  0.24 0.01
HTN: hypertension, DM: diabetes mellitus, TC: total cholesterol, LDL-C: low-density lipoprotein-cholesterol, HDL-C: high-density lipo-
protein-cholesterol, TG: triglyceride, BNP: brain natruretic peptide, peak HR: peak heart rate. CAD: coronary artery disease 
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significant negative association with the post-exercise 
BNP level (p<0.01) (Table 4, Model 1), but the associa-
tion was not as strong as that with the pre-exercise BNP 
level. Models 2 and 3 show adjusted associations for 
each parameter. The BNP change was not significantly 
correlated with HRR in any of the three models (Table 
5, Models 1, 2, 3). Based on our correlation analysis, 
we determined that the pre-exercise BNP level is the most 
reliable measurement of the three BNP measurements 
used in this study.   
  
Discussion  
 
BNP is a hormone that is secreted from the cardiac 
Table 2. Echocardiographic characteristics according to HRR after exercise
  HRR ≤24 pbm (n=44)  HRR >24 bpm (n=61)     p 
Variable 
Total  Men  Women  Total  Men  Women  Total  Men  Women
Peak SBP (mmHg)  178.9±29.1 185.8±31.3 168.9±23.0 182.3±28.5 182.9±29.8 181.3±26.9 0.548 0.71  0.13
Peak DBP (mmHg)  96.1±13.0 97.7±13.1 93.9±12.9 97.5±13.1 95.0±12.2 101.7±13.7 0.588 0.40  0.07
LVEF (%)  61.4±5.0 62.0±5.4 60.4±4.2 61.8±3.7 61.9±4.1 61.6±3.0 0.584  0.99  0.33
LVIDd (cm)  5.0±0.4 5.04±0.4 5.0±0.4 5.0±0.3 5.1±0.3 5.0±0.3 0.740  0.82  0.81
LVIDs (cm)  3.4±0.4 3.4±0.4 3.4±0.3 3.3±0.5 3.4±0.4 3.2±0.6 0.778  0.64  0.38
IVSTd (cm)  0.9±0.1 0.9±0.1 0.9±0.1 0.9±0.1 0.9±0.1 0.9±0.1 0.276  0.32  0.61
E/A ratio  0.8±0.2 0.9±0.2 0.8±0.2 1.0±0.3 1.0±0.3 0.9±0.2 0.025  0.05  0.24
CI (L/min/m
2) 2.6±0.4 2.6±0.5 2.8±0.3 2.6±0.6 2.5±0.7 2.8±0.4 0.701  0.52  0.82
HRR: heart rate recovery, SBP: systolic blood pressure, DBP: diastolic blood pressure, LVEF: left ventricular ejection fraction, LVIDd: left 
ventricular internal dimension at end-diastole, LVIDs: left ventricular internal dimension at end-systole, IVSTd: intraventricular septal 
thickness at end-diastole, CI: cardiac index 
 
Table 3. Correlation analysis of HRR and pre-BNP 
HRR 
 
Model 1  Model 2  Model 3 
Pre-BNP r=-0.36** 
Peak HR: -0.22* 
CAD: -0.28** 
Age: -0.34** 
HTN: -0.36** 
DM: -0.34** 
Peak HR+CAD+Age+HTN+DM: -0.20*
*p<0.05, **p<0.01. Model 1: non-adjusted, Model 2: adjusted for single parameter; peak HR, CAD, age, HTN, DM, Model 3: adjusted for 
multiple parameters; peak HR+CAD+age+HTN+DM. HRR: heart rate recovery, BNP: brain natruretic peptide, peak HR: peak heart rate, 
CAD: coronary artery disease, HTN: hypertension, DM: diabetes mellitus 
 
Table 4. Correlation analysis of HRR and post-BNP 
HRR 
 
Model 1  Model 2  Model 3 
Post-BNP r=-0.27** 
Peak HR: -0.147 
CAD: -0.195* 
Age: -0.250* 
HTN: -0.269** 
DM: -0.245* 
Peak HR+CAD+Age+HTN+DM: -0.123
*p<0.05, **p<0.01. Model 1: non-adjusted, Model 2: adjusted for single parameter; peak HR, CAD, age, HTN, DM, Model 3: adjusted for 
multiple parameters; peak HR+CAD+age+HTN+DM. HRR: heart rate recovery, BNP: brain natriuretic peptide, peak HR: peak heart rate, 
CAD: coronary artery disease, HTN: hypertension, DM: diabetes mellitus 
 
Table 5. Correlation analysis of HRR and BNP change
HRR 
 
Model 1  Model 2  Model 3 
BNP change  r=-0.108 
Peak HR: -0.044 
CAD: -0.069 
Age: -0.097 
HTN: -0.110 
DM: -0.088 
Peak HR+CAD+Age+HTN+DM: -0.022
*p<0.05, **p<0.01. Model 1: non-adjusted, Model 2: adjusted for single parameter; peak HR, CAD, age, HTN, DM, Model 3: adjusted for 
multiple parameters; peak HR+CAD+age+HTN+DM. HRR: heart rate recovery, BNP: brain natriuretic peptide, peak HR: peak heart rate, 
CAD: coronary artery disease, HTN: hypertension, DM: diabetes mellitus 
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ventricles in response to an increase in left ventricular 
pressure and volume. Moreover, elevated plasma BNP 
levels are highly sensitive and specific for the diagnosis 
and prognosis of HF, and for the prognosis of acute 
myocardial infarction.
12)13)15) Patients with HF have bl-
unted HRR concurrent with the presence of higher BNP 
levels.
16) But, the BNP level is typically measured before 
exercise; there is little data on post-exercise BNP levels 
and BNP change during exercise, and few studies have 
considered gender differences in BNP level and HRR. 
We analyzed patients with normal systolic function, and 
found that a rapid decrease in HRR had a significant 
negative association with pre- and post-exercise BNP 
levels, but not with BNP change.   
HRR is defined as the maximum heart rate during 
exercise, minus the heart rate after exercise, which is a 
measure of the actual decrease in heart rate relative to 
the peak heart rate during exercise. Previous studies on 
HRR vary in non-HF patients; the optimal prognostic 
cutoff values for HRR (defining normal vs. abnormal 
HRR) are based on specific statistical considerations or 
are arbitrarily selected. The most commonly used cutoff 
value is 12 beats per minute.
14) We found that patients 
with abnormal HRR values (≤24 beats first 2 minutes 
of HRR) had lower HDL-C, lower peak heart rate, and 
higher pre- and post-exercise BNP levels than patients 
with normal HRR values. In addition, the patients with 
abnormal HRR had a significantly higher prevalence 
of CAD. The higher pre- and post-exercise BNP levels 
in the abnormal HRR group can be explained by 1) 
parasympathetic dysfunction, 2) diastolic dysfunction, 
and 3) CAD.   
First, heart rate variability (HRV) is one of the best 
methods to detect a quantitative relationship between 
the cardiovascular and autonomic nervous system (ANS). 
The ANS-mediated response, in particular parasympa-
thetic reactivation, is a major determinant of HRR. In 
healthy individuals, the parasympathetic system is do-
minant at rest; exercise is associated with parasympa-
thetic withdrawal and, as the intensity of exercise is in-
creased, with sympathetic activity.
19) Savin et al.
19) have 
observed significantly reduced HRR values in indivi-
duals whose parasympathetic systems were blocked with 
atropine after exercise, suggesting that parasympathetic 
reactivation, not sympathetic withdrawal, is responsi-
ble for the reduced heart rate in the recovery phase. 
Abnormal HRR is considered a manifestation of alter-
ed autonomic responsiveness and abnormal vagal tone, 
possibly leading to an increased heart rate at rest.
20)  
Second, an increase in BNP reportedly reflects an 
early stage of cardiac dysfunction.
21) Increased levels of 
plasma BNP are related to cardiac reflex parasympathe-
tic dysfunction. The early stage of cardiac function and 
parasympathetic dysfunction may be associated with 
increased plasma BNP levels.
17) In our study, there was 
a significant correlation between delayed HRR and two 
BNP measurements, pre- and post-exercise. Multivariate 
analysis revealed that impaired HRR after exercise is 
significantly related with age and diastolic dysfunction.
22) 
But in this study, the abnormal HRR group showed a 
significantly lower E/A ratio than the normal HRR 
group. The discrepancy between this study and other 
studies may be explained by differences in ventricular 
function. All subjects in this study have normal sys-
tolic function. In systolic failure, the heart overfills to 
compensate for the reduced pump function, which leads 
to chamber dilation and remodeling. However, in many 
older patients with HTN and ventricular hypertrophy 
that develop HF, dilatation does not occur.
23) This re-
sults in the EF remaining in the normal range with a 
limited cardiac output reserve.
24) The beneficial effects 
of BNP may be particularly important in hypertensive 
patients with decompensated HF, who demonstrated 
markedly reduced maximum exercise capacity compared 
with the reference values from healthy subjects.
25)26) The 
E/A ratio included in this study can reflect only parti-
ally the diastolic dysfunction. This study compared the 
BNP levels of patients with a normal systolic function 
at rest and the HRR while they were exercising, and we 
found a difference in the E/A ratio according to HRR. 
Therefore, diastolic dysfunction could have substantial-
ly affected the results of this study. Although there is a 
significant correlation between BNP and HRR, even 
after correcting for confounding factors, the possibility 
of a difference in the HRR due to diastolic dysfunction 
cannot be ruled out. There are a number of potential 
areas in which the investigation of HRR and diastolic 
dysfunction could be expanded in future studies. 
Third, patients with CAD had a significantly slower 
decrease in HRR.
27) There was a strong correlation be-
tween the chronotropic variables (peak HR, percent peak 
HR and HRR after exercise) in the normal and CAD 
groups.
18) In our study, patients with CAD also had a re-
duced HRR. The abnormal HRR group had a signifi-
cantly higher prevalence of CAD than the normal HRR 
group (52% vs. 28%, respectively, p=0.011), as shown 
in Table 1. Also, in Table 3 and 4, pre- and post-exer-
cise BNP levels had a negative correlation with HRR. 
This correlation was still significant after adjusting for 
CAD, but the correlation values decreased more than 
for other parameters such as age, HTN, and DM. This 
result is consistent with previous findings related to the 
relationship between BNP and CAD.
15)25)28)  
A comparative study on N-terminal pro-BNP concen-
trations indicated that the patients with unstable an-
gina had higher BNP blood levels than stable patients.
18) 
Changes in serum natruretic peptide levels in patients 
without HF are closely correlated with the presence of 
exercise-induced myocardial ischemia.
28) Revasculariza-
tion can partially restore HRV during the 6 months fol- 
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lowing PTCA, suggesting that ischemia is one cause of 
the HRV.
29) In this study, we performed CAG in patients 
with normal systolic function. CAD affected BNP and 
HRR, but there was a significant correlation between 
pre- and post-exercise BNP levels, and with HRR, even 
after correcting for CAD. This result suggests that the 
BNP level is affected more by HRR than by CAD, but 
further study is still needed.   
This study has several limitations. First, our study was 
a cross-sectional survey and could not determine cause-
and-effect relationships. Second, our study subjects may 
not be fully representative of the general adult popul-
ation because they were enrolled based on the present-
ing complaint of chest pain. Third, our study had a re-
latively small sample size available for analysis. Further-
more, the study group consisted of carefully selected 
patients, recruited based on specific inclusion and ex-
clusion criteria. Our findings need to be confirmed in 
a larger, community-based, non-selective HF cohort. 
Further, this study did not take into account diastolic 
dysfunction, which substantially affects the HRR and 
BNP. The E/A ratio cannot measure diastolic function 
fully. Lastly, this study did not investigate the smoking 
history of the subjects. Sidney et al.
30) have reported that 
smoking is associated with a faster HRR, possibly because 
smoking-related beta-receptor down-regulation results 
in a blunted HR response to exercise.   
In conclusion, HRR was independently associated 
with pre- and post-exercise BNP levels, but not BNP ch-
anges during exercise, even in patients with normal sys-
tolic function. The strongest association was between 
HRR and pre-exercise BNP levels. BNP change was less 
important than pre- and post-exercise BNP levels; there-
fore, pre-exercise BNP levels are the most powerful para-
meter in this study. BNP is a marker for HF, HTN, and 
myocardial infarction, as well as potentially for autono-
mic function. Prospective studies and research are still 
necessary for conformation. 
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